SCHEMBL8729424

SCHEMBL8729424

N=C(N)NNC(=O)c1ccncc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.73
CA1 P00915 3/20 0.68
CA9 Q16790 3/20 0.68
TP53 P04637 1/20 0.61
KDM4E B2RXH2 1/20 0.57
MPO P05164 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2A6 P11509 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
PTGS2 P35354 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
GAA P10253 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 2/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3000231 0.86 ALDH1A1 (0.83) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL2992964 0.85 ALDH1A1 (1.00) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL16785428 0.82 ALDH1A1 (0.76) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL2998472 0.81 CA1 (1.00) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL5468686 0.80 RAB9A (0.59) ALDH1A1CA1CA9KDM4ECYP3A4
SCHEMBL2988323 0.79 ALDH1A1 (0.86) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL5464442 0.78 APEX1 (0.52) ALDH1A1CA1CA9KDM4EMPO
SCHEMBL28701752 0.78 KDM4E (0.53) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL10652021 0.78 ALDH1A1 (0.68) ALDH1A1CA1CA9TP53KDM4E
SCHEMBL2986200 0.78 ALDH1A1 (0.83) ALDH1A1CA1CA9TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750545-A EXHIBIT EOSINOPHIL-INHIBITORY ACTION AND LYMPHOCYTE ACTIVATION-INHIBITORY ACTION; USEFUL FOR TREATMENT OF IMMUNE-RELATED DISEASES THE GREEN CROSS CORPORATION (JP) 1998-05-12 US disclosed
EP-0710654-A1 TRIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF THE GREEN CROSS CORPORATION (JP) 1996-05-08 EP disclosed